DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a…
| Price | $7.17 |
|---|---|
| Market cap | $52.42M |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Exchange | NASDAQ |
| 52-week range | 5.845-17.744 |
| Beta | 1.12 |
Explore DRIO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.